Health
J&J Covid-19 vaccine performs well in early tests – Financial Times
Experimental inoculation elicits ‘robust’ immune response when used on animals
A single dose of Johnson & Johnson’s experimental coronavirus vaccine elicited “robust” protection against Covid-19 when tested on animals, with clinical human trials now under way in the US and Belgium.
The pre-clinical data, published in Nature magazine, show the drugmaker’s dose successfully prevented subsequent infection in non-human primates, spurring so-called “neutralising antibodies”. It also provided complete or near-complete protection against Covid-19 in their lungs.
“The findin…
-
General24 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
Noosa News9 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General13 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba